Proteasomal inhibition stabilizes topoisomerase IIα protein and reverses resistance to the topoisomerase II poison ethonafide (AMP-53, 6-ethoxyazonafide)-Reference-Cited by-同舟云学术

Proteasomal inhibition stabilizes topoisomerase IIα protein and reverses resistance to the topoisomerase II poison ethonafide (AMP-53, 6-ethoxyazonafide)

Published:2008-02 Issue:4 Volume:75 Page:883-890
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Congdon Lauren M.,Pourpak Alan,Escalante Aluvia M.,Dorr Robert T.,Landowski Terry H.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference26 articles.

1. New treatments for multiple myeloma;Richardson;Oncology (Williston Park),2005

2. Culprit and victim—DNA topoisomerase II;Kellner;Lancet Oncol,2002

3. Topoisomerase II and the response to antileukemic therapy;Kaufmann;Leuk Lymphoma,1998

4. A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription;Ju;Science,2006

5. DNA topoisomerase II as a target for cancer chemotherapy;Walker;Cancer Invest,2002

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MDM2 provides TOP2 poison resistance by promoting proteolysis of TOP2βcc in a p53-independent manner;Cell Death & Disease;2024-01-23

2. Design, synthesis, and biological evaluation of novel HDAC inhibitors with a 3-(benzazol-2-yl)quinoxaline framework;Bioorganic & Medicinal Chemistry Letters;2023-05

3. Recent Developments of Target Based Coumarin Derivatives as Potential Anticancer Agents;Mini-Reviews in Medicinal Chemistry;2020-11-18

4. Recent Developments of Target-Based Benzimidazole Derivatives as Potential Anticancer Agents;Heterocycles - Synthesis and Biological Activities;2020-06-10

5. l,8-Naphthalimide based DNA intercalators and anticancer agents. A systematic review from 2007 to 2017;European Journal of Medicinal Chemistry;2018-11